Edwards Lifesciences

A choice of hemodynamic monitoring options to meet your clinical needs.

Edwards Lifesciences’ advanced hemodynamic monitoring and management systems enable individualized hemodynamic optimization. The systems provide clarity into patient status, helping clinicians make more informed volume management decisions in their moderate- to high-risk surgery patients. Edwards’ extensive line of hemodynamic management sensors, catheters and cuffs enable clinicians to make proactive clinical decisions in the operating room (OR) and ICU.

Hemodynamic instability may increase with more complicated or invasive procedures and with the presence of various comorbidities. As a result, clinicians’ hemodynamic monitoring needs and preferences may vary with the complexity of each procedure and patient. Edwards provides a range of monitoring options that can be used in perioperative goal-directed therapy (PGDT) protocols to maintain patients in the optimal volume range. Further, the Edwards Enhanced Surgical Recovery Program can help implement hemodynamic optimization through PGDT in moderate- to high-risk surgery procedures.

The noninvasive ClearSight system extends the clarity of continuous hemodynamic monitoring to moderate- and high-risk surgery patients, including elderly or obese patients in whom an arterial catheter would not typically be placed. Parameters monitored include stroke volume (SV), stroke volume variation (SVV), cardiac output (CO) and continuous blood pressure (cBP).

The minimally invasive FloTrac sensor connects to an existing arterial line to continuously provide dynamic, flow-based parameters that can be used in PGDT protocols. It is a practical solution for making informed volume management decisions in your moderate- and high-risk surgery patients. The FloTrac sensor has been chosen by clinicians more than any other minimally invasive volume management solution to monitor over 2.5 million patients worldwide.*

The Edwards PreSep oximetry catheter continuously measures a patient’s central venous oxygen saturation (ScvO₂), providing an earlier and more global view of tissue oxygenation and consumption.

The Swan-Ganz pulmonary artery catheter with advanced monitoring capability provides a single, integrated hemodynamic profile for the most complex patients. The Edwards Swan-Ganz catheter remains the leading pulmonary artery catheter for surgical, critical care and trauma patients worldwide.*

The EV1000 clinical platform provides a variety of informative screens from which to choose to provide immediate insight and guide your therapeutic interventions. The platform also allows you to select the parameters most significant for your monitoring requirements, enabling you to make more informed decisions and determine the best course of action.

The EV1000 clinical platform presents the physiologic and hemodynamic status of the patient in an intuitive and meaningful way. Designed to work with the ClearSight finger cuff, FloTrac sensor and Edwards PreSep oximetry catheter, the platform offers the scalability and adaptability for both the OR and ICU.

Edwards VAMP (Venous Arterial blood Management Protection) closed-loop blood sampling system is a needleless, closed blood sampling system designed to reduce infection,^1,2 needlesticks³ and blood waste^4,5 associated with conventional blood sampling methods. The TruWave pressure transducer can be paired with the VAMP system for combined accuracy and reliability with the safety of a single, seamless foundational monitoring solution.

Edwards offers an extensive line of education and support tools to facilitate the integration of advanced hemodynamic monitoring in OR and ICU settings. Visit www.Edwards.com/​CCeducation to review perioperative patient simulations, simulated case studies, product animations and more. Or, visit youtube.com/​ECCE4you for OR- and ICU-specific playlists.

With more than 40 years of collaborating with clinicians to advance patient care, Edwards is committed to developing solutions that provide the clarity and control to make more informed decisions.

References

1. Walrath JM, et al. Stopcock: bacterial contamination in invasive monitoring systems. Heart Lung. 1979;8(1):100-104.
2. Shinozaki T, et al. Bacterial contamination of arterial lines. A prospective study. JAMA. 1983;249(2):223-235.
3. Tan L, et al. Report of the Council on Scientific Affairs: preventing needlestick injuries in health care settings. JAMA Intern Med. 2001;61(7):929-936.
4. Barth MD, et al. Blood conservation: what is current blood draw practice? J Infus Nurs. 2013;36(5):323-328.
5. Smoller BR, et al. Reducing adult phlebotomy blood loss with the use of pediatric-sized blood collection tubes. Am J Clin Pathol. 1989;91(6):701-703.

*Data on file.

Caution: Federal (United States) law restricts this device to sale by or on the order of a physician. See instructions for use for full prescribing information, including indications, contraindications, warnings, precautions and adverse events.

Edwards, Edwards Lifesciences, the stylized E logo, Enhanced Surgical Recovery Program, ClearSight, EV1000, FloTrac, PreSep, Swan-Ganz, TruWave and VAMP are trademarks of Edwards Lifesciences Corporation.

This corporate profile was reviewed and approved by Edwards Lifesciences.

Close